Urinary Tract Infections

Prevention, recognition, and medical care guidance for urinary tract infections in ADPKD patients.

⚠ Medical Safety Notice

This website provides health education for ADPKD patients and their families. It does not provide diagnosis, prescriptions, dosing, or individualized treatment plans. Always discuss medical decisions with your nephrologist. In emergencies, seek immediate medical care or call your local emergency number.

Why ADPKD Patients Are More Prone to Urinary Tract Infections

The prevalence of urinary tract infections (UTIs) in ADPKD patients is approximately 30–50%, higher than in the general population. The cyst structure leads to impaired urine drainage, and the environment within cysts is conducive to bacterial growth β€” these are the main reasons. Cyst infections are more difficult to treat than ordinary UTIs.

Recognition: Cyst Infection vs. Ordinary UTI

Feature Ordinary UTI Cyst Infection
Fever Usually absent or low-grade High fever and chills common
Flank pain May or may not be present Marked unilateral flank pain
Urine culture Often positive May be negative (cyst fluid does not communicate with urine)
Treatment Oral antibiotics; short course Intravenous antibiotics required; long course (4–6 weeks)

Prevention Strategies

Information to Provide When Seeking Medical Care

About Antibiotics

Antibiotic selection must be determined by a physician based on urine culture results. Cyst infections in ADPKD patients require antibiotics that can penetrate the cyst wall (such as fluoroquinolones). Do not self-medicate or use leftover antibiotics from a previous prescription.

References

  1. KDIGO 2025 Clinical Practice Guideline on the Evaluation and Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) β€” KDIGO. Kidney International, 2025. DOI: 10.1016/j.kint.2024.07.010. View source
  2. Chinese Guideline for the Diagnosis and Treatment of Autosomal Dominant Polycystic Kidney Disease (2024 Edition) β€” Chinese Society of Nephrology, Chinese Medical Association. Chinese Journal of Nephrology, 2024. View source
  3. Diuretics in patients with chronic kidney disease β€” Ellison DH, et al. Nature Reviews Nephrology, 2024. DOI: 10.1038/s41581-024-00918-x. View source
Evidence level: A (current guidelines and high-quality evidence)
Limitations: This content Individual circumstances vary greatly β€” always consult your nephrologist.

← Back to Knowledge Base